Defective function of lymphokine‐activated killer cells and natural killer cells in patients with hepatocellular carcinoma
Toshiji Saibara, Saburo Onishi, Hiroshi Sakaeda, Yasutake Yamamoto – 1 March 1989 – Lymphokine‐activated killer activity and natural killer activity in hepatocellular carcinoma patients were assessed. Maximum lymphokine‐activated killer activity was induced at 3 to 5 days of incubation, and lymphokine‐activated killer activity tended to increase in a manner dose dependent of recombinant interleukin‐2. However, the maximum increase of lymphokine‐activated killer activity in hepatocellular carcinoma was not as high as that of normal subjects or liver cirrhosis patients.